ストックスクリーナーアプリを入手
3.50
1.41%
-0.05
プレマーケット:
3.49
-0.010
-0.29%
Nuwellis Inc (NUWE) 最新ニュース
Momentum divergence signals in Nuwellis Inc. chartJuly 2025 Pullbacks & High Conviction Buy Zone Alerts - newser.com
Is Nuwellis Inc. reversing from oversold territoryDollar Strength & High Yield Equity Trading Tips - newser.com
Key resistance and support levels for Nuwellis Inc.Short Setup & Weekly Market Pulse Updates - newser.com
Will Nuwellis Inc. stock go up soonWeekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Combining machine learning predictions for Nuwellis Inc.Quarterly Profit Review & Daily Growth Stock Investment Tips - newser.com
Why Nuwellis Inc. is moving todayWeekly Trade Report & High Yield Equity Trading Tips - newser.com
Nuwellis Appoints John L. Erb as Interim CFO - TipRanks
NuwellisRobert B. Scott resigns as CFO of Nuwellis - MarketScreener
Nuwellis Receives NIH Grant to Advance its Pediatric CRRT Platform - Medical Product Outsourcing
Nuwellis Inc Stock Analysis and ForecastInsider Trading Activity & Outperform the Market with Aggressive Picks - earlytimes.in
What drives Nuwellis Inc stock priceSector-Based Investing & Small Investment Trading Plans - earlytimes.in
Tools to assess Nuwellis Inc.’s risk profilePortfolio Value Report & Real-Time Market Trend Scan - newser.com
How interest rate cuts could boost Nuwellis Inc. stock2025 Growth vs Value & AI Enhanced Trading Signals - newser.com
Can technical indicators confirm Nuwellis Inc.’s reversalMarket Risk Summary & Growth Focused Investment Plans - newser.com
What momentum shifts mean for Nuwellis Inc.2025 Pullback Review & Verified Momentum Watchlists - newser.com
Using RSI to spot recovery in Nuwellis Inc.Trade Risk Report & Verified Technical Signals - newser.com
Nuwellis Announces ULTRA-Peds Registry Findings - TipRanks
Nuwellis announces findings from ULTRA-Peds registry on Aquadex System use - Investing.com
Nuwellis reports 92% survival rate in pediatric Aquadex therapy study - Investing.com
Nuwellis reports 92% survival rate in pediatric Aquadex therapy study By Investing.com - Investing.com Australia
Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex® - The Manila Times
Nuwellis, Inc. Announces Positive Findings from ULTRA-Peds Registry on Aquadex Therapy for Critically Ill Children - Quiver Quantitative
How moving averages guide Nuwellis Inc. tradingProfit Target & AI Based Trade Execution Alerts - newser.com
Is Nuwellis Inc. showing signs of accumulation2025 Price Action Summary & Smart Investment Allocation Tips - newser.com
Detecting support and resistance levels for Nuwellis Inc.Gap Down & Comprehensive Market Scan Reports - newser.com
Is Nuwellis Inc a good long term investmentMarket Capitalization Trends & Smart Beta Strategies That Actually Work - Early Times
Nuwellis, Inc. Stock Plummets to New 52-Week Low of $3.54 - Markets Mojo
Nuwellis introduces 24-hour circuit for Aquadex therapy in the U.S. - MSN
Nuwellis, Inc. Stock Plummets to New 52-Week Low of $3.65 - Markets Mojo
Earnings Report: Does Nuwellis Inc have pricing powerJuly 2025 Catalysts & Real-Time Buy Zone Alerts - خودرو بانک
Technical Analysis: What is the earnings history of Nuwellis IncWeekly Profit Recap & Target Return Focused Picks - خودرو بانک
Will Nuwellis Inc. benefit from macro trendsWeekly Stock Report & High Accuracy Trade Alerts - newser.com
Nuwellis Secures New Patent for Hemolysis Sensors - TipRanks
Nuwellis receives patent for hemolysis detection in blood filtration systems By Investing.com - Investing.com South Africa
Nuwellis receives new U.S. patent reinforcing Vivian pediatric device - TipRanks
1.83%
大文字化:
|
ボリューム (24 時間):